Appointment of Joint Broker

Summary by AI ^BETAClose X

Develop North PLC has appointed AlbR Capital Limited as Joint Corporate Broker with immediate effect. This announcement does not include any new financial figures or data that would directly impact the company's stock share price.

Disclaimer*

Develop North PLC

17 June 2026

DEVELOP NORTH PLC

(the "Company" or "DVNO" or "Develop North")

(LEI: 213800EXPWANYN3NEV68)

Appointment of Joint Broker

Develop North PLC, the North East England based investment company, is pleased to announce the appointment of AlbR Capital Limited as Joint Corporate Broker to the Company with immediate effect.

Enquiries:

Develop North PLC Michelle Percy	+44 (0) 191 222 0099
Tier One Capital Ltd (Investment Adviser) Brendan O'Grady	+44 (0) 191 222 0099
Cavendish Capital Markets Limited (Financial Adviser and Joint Corporate Broker) Robert Peel Andrew Worne Oscar Valeur-Adu	+44 (0) 207 220 0500
AlbR Capital Limited (Joint Corporate Broker)	+44(0) 207 469 0930
Alma Strategic Communications (Financial Communications Adviser) Andrew Jaques Joe Pederzolli Louisa El-Ahwal	+44 (0) 203 405 0211
Apex Fund Administration Services (UK) Limited (Secretary)	+44 (0) 1245 398950

Notes to Editors:

Develop North PLC's investment objective is to provide shareholders with a consistent and stable income and the potential for an attractive total return over the medium to long term, through a diversified portfolio of investments predominantly in the North East of England.

The Company has the financial strength, credibility and professionalism expected of a business listed on the London Stock Exchange, while also offering the flexibility, creativity and common sense of an approachable, local business.

Since the Company's IPO in 2017, it has invested almost £90 million of capital into the North of England and Scotland and has helped support an estimate 12,000 jobs with a gross development value of more than £280 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END